Clinical trial

Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable…

NCT00081211 · National Cancer Institute (NCI), NIH · Terminated

Key facts

NCT number NCT00081211
Title Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck
Official title A Phase I Study Of PV701 In Patients With Head And Neck Squamous Cell Carcinoma
Lead sponsor National Cancer Institute (NCI), NIH
Status Terminated
Phase Phase 1
Study type Interventional
Conditions Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Salivary Gland Squamous Cell Carcinoma, Stage III Salivary Gland Cancer, Stage III Squamous Cell Carcinoma of the Hypopharynx and 12 more
Intervention type Biological
Interventions PV701
Enrollment 30
Start date Apr 1, 2004
Primary completion Jul 1, 2004
First posted Apr 8, 2004
Last update posted Jan 24, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies